These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8987977)

  • 1. Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo.
    Tsiang M; Paborsky LR; Li WX; Jain AK; Mao CT; Dunn KE; Lee DW; Matsumura SY; Matteucci MD; Coutré SE; Leung LL; Gibbs CS
    Biochemistry; 1996 Dec; 35(51):16449-57. PubMed ID: 8987977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redesigning allosteric activation in an enzyme.
    Rana S; Pozzi N; Pelc LA; Di Cera E
    Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5221-5. PubMed ID: 21368156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the A chain in thrombin function.
    Papaconstantinou ME; Bah A; Di Cera E
    Cell Mol Life Sci; 2008 Jun; 65(12):1943-7. PubMed ID: 18470478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redesigning the monovalent cation specificity of an enzyme.
    Prasad S; Wright KJ; Banerjee Roy D; Bush LA; Cantwell AM; Di Cera E
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13785-90. PubMed ID: 14612565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the activation peptide in the mechanism of protein C activation.
    Stojanovski BM; Pelc LA; Di Cera E
    Sci Rep; 2020 Jul; 10(1):11079. PubMed ID: 32632109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WEDGE: an anticoagulant thrombin mutant produced by autoactivation.
    Wood DC; Pelc LA; Pozzi N; Wallisch M; Verbout NG; Tucker EI; Gruber A; Di Cera E
    J Thromb Haemost; 2015 Jan; 13(1):111-4. PubMed ID: 25369995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling of thrombus formation using smoothed particle hydrodynamics method.
    Monteleone A; Viola A; Napoli E; Burriesci G
    PLoS One; 2023; 18(2):e0281424. PubMed ID: 36745608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mathematical model to quantify the effects of platelet count, shear rate, and injury size on the initiation of blood coagulation under venous flow conditions.
    Bouchnita A; Terekhov K; Nony P; Vassilevski Y; Volpert V
    PLoS One; 2020; 15(7):e0235392. PubMed ID: 32726315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Heterozygous Variant in F2 Gene in a Chinese Patient With Coronary Thrombosis and Acute Myocardial Infarction Leads to Antithrombin Resistance.
    Tang Y; Zhang L; Xie W; Jin J; Luo Y; Deng M; Liu Z; Pan HW; Zhang Y; Zheng Z; Fan LL
    Front Genet; 2020; 11():184. PubMed ID: 32194638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protein C activator AB002 rapidly interrupts thrombus development in baboons.
    Tucker EI; Verbout NG; Markway BD; Wallisch M; Lorentz CU; Hinds MT; Shatzel JJ; Pelc LA; Wood DC; McCarty OJT; Di Cera E; Gruber A
    Blood; 2020 Feb; 135(9):689-699. PubMed ID: 31977000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residues W215, E217 and E192 control the allosteric E*-E equilibrium of thrombin.
    Pelc LA; Koester SK; Chen Z; Gistover NE; Di Cera E
    Sci Rep; 2019 Aug; 9(1):12304. PubMed ID: 31444378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between conformational selection and zymogen activation.
    Chakraborty P; Acquasaliente L; Pelc LA; Di Cera E
    Sci Rep; 2018 Mar; 8(1):4080. PubMed ID: 29511224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational Design of Protein C Activators.
    Barranco-Medina S; Murphy M; Pelc L; Chen Z; Di Cera E; Pozzi N
    Sci Rep; 2017 Mar; 7():44596. PubMed ID: 28294177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neprilysin Inhibits Coagulation through Proteolytic Inactivation of Fibrinogen.
    Burrell M; Henderson SJ; Ravnefjord A; Schweikart F; Fowler SB; Witt S; Hansson KM; Webster CI
    PLoS One; 2016; 11(7):e0158114. PubMed ID: 27437944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis.
    Lechtenberg BC; Murray-Rust TA; Johnson DJ; Adams TE; Krishnaswamy S; Camire RM; Huntington JA
    Blood; 2013 Oct; 122(16):2777-83. PubMed ID: 23869089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational selection in trypsin-like proteases.
    Pozzi N; Vogt AD; Gohara DW; Di Cera E
    Curr Opin Struct Biol; 2012 Aug; 22(4):421-31. PubMed ID: 22664096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombomodulin is required for the antithrombotic activity of thrombin mutant W215A/E217A in a mouse model of arterial thrombosis.
    Vicente CP; Weiler H; Di Cera E; Tollefsen DM
    Thromb Res; 2012 Oct; 130(4):646-8. PubMed ID: 22178578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of Factor XIII V34X activation peptides to control ability to interact with thrombin mutants.
    Jadhav MA; Lucas RC; Goldsberry WN; Maurer MC
    Biochim Biophys Acta; 2011 Dec; 1814(12):1955-63. PubMed ID: 21798378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New anticoagulants: how to deal with treatment failure and bleeding complications.
    Kazmi RS; Lwaleed BA
    Br J Clin Pharmacol; 2011 Oct; 72(4):593-603. PubMed ID: 21752066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allostery in trypsin-like proteases suggests new therapeutic strategies.
    Gohara DW; Di Cera E
    Trends Biotechnol; 2011 Nov; 29(11):577-85. PubMed ID: 21726912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.